| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −0.7× | −1.7× | |
| Price / Book | 0.9× | 2.0× | |
| Price / Sales | 0.6× | 4.0× | |
| Price / Free cash flow | −0.9× | −1.6× | |
| EV / EBITDA | −0.2× | −1.2× | |
| Earnings yield | −148.2% | −14.3% | |
| Free cash flow yield | −113.3% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,292.64 | +4.22% | $1.22T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.11 | +2.10% | $624.43B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $289.00 | +2.24% | $510.7B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $422.17 | +3.76% | $378.94B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $147.83 | +2.92% | $364.72B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.26 | +2.04% | $282.53B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.45 | +2.74% | $261.25B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $688.19 | +1.30% | $254.46B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $434.82 | +2.33% | $235.08B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.29 | +1.45% | $192.55B | 22.3× | 37.5% | +29.9% |
